FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to traumatology and orthopaedics, and can be used for treating knee osteoarthritis. Patient is injected intra-articularly with a solution prepared by dissolving a lyophilisate of dalargin in amount of 1.0 mg in 1 ml of 2.4% hyaluronic acid solution for injections with a molecular weight of more than 1,000,000 Da, three times every 7 days.
EFFECT: invention provides an effective method of treating osteoarthritis.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OSTEOARTHRITIS WITH COMBINATION OF DALARGIN AND POLYACLYLAMIDE | 2024 |
|
RU2828962C1 |
| KNEE OSTEOARTHRITIS TREATMENT GEL | 2024 |
|
RU2833711C1 |
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
| GEL FOR TREATING DIABETIC POLYNEUROPATHY OF LOWER EXTREMITIES | 2024 |
|
RU2829250C1 |
| METHOD FOR TREATING OSTEOARTHROSIS OF KNEE JOINT | 2017 |
|
RU2688176C2 |
| METHOD FOR SURGICAL MANAGEMENT OF MEDIAL OSTEOARTHRITIS OF KNEE JOINT | 2023 |
|
RU2816801C1 |
| AGENT FOR TREATING DEGENERATIVE PROCESSES OF MUSCULOSKELETAL SYSTEM | 2024 |
|
RU2827071C1 |
| CELLULITE TREATMENT GEL | 2024 |
|
RU2829491C1 |
| HYDROGEL FOR TREATING PRESSURE ULCERS | 2024 |
|
RU2835419C1 |
| PROPHYLACTIC MEDICATION, AND/OR THERAPEUTIC MEDICATION, AND/OR AGGRAVATION-SUPPRESSING MEDICATION IN CASE OF ARTHRITIS DEFORMANS IN HUMANS | 2010 |
|
RU2569754C2 |
